- Research works
- 4 ▼ 90% vs 2013–17
- Citations
- 37 9.2 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 50% world 28%
Not ranked overall: Novartis (Israel) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Novartis (Israel) publish most on?
By volume in 2022–2025: Hemoglobinopathies and Related Disorders, Kruppel-like factors research and Myeloproliferative Neoplasms: Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hemoglobinopathies and Related Disorders Genetics 0 works
- 2 Kruppel-like factors research Molecular Biology 0 works
- 3 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Novartis (Israel)'s research output changed?
Output in 2018–2022 was 90% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tel Aviv
- Tel Aviv University
- Tel Aviv Sourasky Medical Center
- Assaf Harofeh Medical Center
- General Electric (Israel)
- Israel Atomic Energy Commission
- Clalit Health Services
- Academic College of Tel Aviv-Yafo
- Meta (Israel)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.